14-87934106-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000153.4(GALC):​c.*626C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 1,496,608 control chromosomes in the GnomAD database, including 166,121 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 19129 hom., cov: 34)
Exomes 𝑓: 0.46 ( 146992 hom. )

Consequence

GALC
NM_000153.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.12
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 14-87934106-G-A is Benign according to our data. Variant chr14-87934106-G-A is described in ClinVar as [Benign]. Clinvar id is 314739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GALCNM_000153.4 linkuse as main transcriptc.*626C>T 3_prime_UTR_variant 17/17 ENST00000261304.7 NP_000144.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GALCENST00000261304.7 linkuse as main transcriptc.*626C>T 3_prime_UTR_variant 17/171 NM_000153.4 ENSP00000261304 P1P54803-1
GALCENST00000544807.6 linkuse as main transcriptc.1744-107C>T intron_variant 2 ENSP00000437513 P54803-5
GALCENST00000555000.5 linkuse as main transcriptc.1279-107C>T intron_variant, NMD_transcript_variant 2 ENSP00000450472

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74806
AN:
151854
Hom.:
19099
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.500
Gnomad AMR
AF:
0.397
Gnomad ASJ
AF:
0.490
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.423
Gnomad FIN
AF:
0.479
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.478
Gnomad OTH
AF:
0.487
GnomAD4 exome
AF:
0.463
AC:
622699
AN:
1344636
Hom.:
146992
Cov.:
24
AF XY:
0.462
AC XY:
305847
AN XY:
661946
show subpopulations
Gnomad4 AFR exome
AF:
0.609
Gnomad4 AMR exome
AF:
0.328
Gnomad4 ASJ exome
AF:
0.473
Gnomad4 EAS exome
AF:
0.198
Gnomad4 SAS exome
AF:
0.409
Gnomad4 FIN exome
AF:
0.459
Gnomad4 NFE exome
AF:
0.477
Gnomad4 OTH exome
AF:
0.453
GnomAD4 genome
AF:
0.493
AC:
74889
AN:
151972
Hom.:
19129
Cov.:
34
AF XY:
0.488
AC XY:
36245
AN XY:
74250
show subpopulations
Gnomad4 AFR
AF:
0.603
Gnomad4 AMR
AF:
0.396
Gnomad4 ASJ
AF:
0.490
Gnomad4 EAS
AF:
0.187
Gnomad4 SAS
AF:
0.424
Gnomad4 FIN
AF:
0.479
Gnomad4 NFE
AF:
0.478
Gnomad4 OTH
AF:
0.491
Alfa
AF:
0.495
Hom.:
4076
Bravo
AF:
0.489
Asia WGS
AF:
0.398
AC:
1382
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Galactosylceramide beta-galactosidase deficiency Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.3
DANN
Benign
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs432946; hg19: chr14-88400450; API